AFM and obesity due to melanocortin 4 receptor deficiency: In the study, increased afamin levels were linked with metabolic syndrome markers such as high blood glucose, dyslipidemia, obesity, high blood pressure, type 2 diabetes mellitus, and pre-eclampsia [16,33].